Clinical Trials List
2017-11-01 - 2021-05-20
Phase III
Terminated9
ICD-10C22
Malignant neoplasm of liver and intrahepatic bile ducts
ICD-10C22.0
Liver cell carcinoma
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yi-Ping Hung Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- Yi-Hsiang Huang Digestive System Department
- Ming-Huang Chen Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Radiology
- San-Chi Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
2 Stop recruiting
Audit
None
Co-Principal Investigator
- Chiu Hung Chiu Division of General Internal Medicine
- Pin-Nan Cheng Division of General Internal Medicine
- 簡世杰 Division of General Internal Medicine
- Yih-Jyh Lin Division of General Internal Medicine
- 姜乃榕 Division of General Internal Medicine
- 邱彥程 Division of General Internal Medicine
- Liu Yi-Sheng Division of General Internal Medicine
- 吳毅晉 Division of General Internal Medicine
- Nai-Jung Chiang Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Audit
None
Co-Principal Investigator
- 洪肇宏 Division of Radiation Therapy
- 郭垣宏 Division of Radiation Therapy
- 陳彥仰 Division of Radiation Therapy
- 紀廣明 Division of Radiation Therapy
- 顏毅豪 Division of Radiation Therapy
- 許獻文 Division of Radiation Therapy
- 盧勝男 Division of Radiation Therapy
- 陳建宏 Division of Radiation Therapy
- 饒坤銘 Division of Radiation Therapy
- 張國欽 Division of Radiation Therapy
- 蔡明釗 Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 許家豪 外科及內科部
- Po-Heng Chuang 外科及內科部
- Hsueh-Chou Lai 外科及內科部
- 楊宏仁 外科及內科部
- Li-Yuan Bai 外科及內科部
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 吳宜穎 Division of Hematology & Oncology
- 陳登偉 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 黃子權 Division of Hematology & Oncology
- 樊修龍 Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- 葉人華 Division of Hematology & Oncology
- 謝財源 Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
- 陳佳宏 Division of Hematology & Oncology
- 施宇隆 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
Audit
None
Taiwan National PI
Co-Principal Investigator
- Ming-Mo Hou Division of General Surgery
- Chien-Hao Huang Division of General Surgery
- 黃振洋 Division of General Surgery
- Tsai-Sheng Yang Division of General Surgery
- Wei-Chen Lee Division of General Surgery
- Ming-Chin Yu Division of General Surgery
- Chen-Chun Lin Division of General Surgery
- Chia-Hsun Hsieh Division of General Surgery
- 潘廣澤 Division of General Surgery
- Shi-Ming Lin Division of General Surgery
- Kun-Ming Chan Division of General Surgery
- 呂嘉偉 Division of General Surgery
The Actual Total Number of Participants Enrolled
1 Stop recruiting
Audit
None
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14 participants
-
Global
674 participants
